CTCSX | VEXRX | CTCSX / VEXRX | |
Total Expense Ratio | 2.05 | 0.33 | 621% |
Annual Report Gross Expense Ratio | 2.10 | 0.33 | 636% |
Fund Existence | 4 years | 24 years | - |
Gain YTD | 15.582 | 5.232 | 298% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 50000 | 5% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 521M | 20.5B | 3% |
Annual Yield % from dividends | 1.61 | 0.50 | 322% |
Returns for 1 year | 33.93 | 2.61 | 1,300% |
Returns for 3 years | 62.68 | 22.01 | 285% |
Returns for 5 years | N/A | 12.06 | - |
Returns for 10 years | N/A | 31.16 | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
BBP | 70.31 | 1.02 | +1.48% |
Virtus LifeSci Biotech Products ETF | |||
NUDM | 36.81 | 0.20 | +0.55% |
Nuveen ESG Intl Dev Mkts Eq ETF | |||
FLUD | 25.05 | 0.04 | +0.15% |
Franklin Ultra Short Bond ETF | |||
SHYG | 43.13 | 0.02 | +0.05% |
iShares 0-5 Year High Yield Corp Bd ETF | |||
MLPD | 25.41 | -0.02 | -0.07% |
Global X MLP & Engy Infras Cov Cll ETF |